Executive Remuneration

GlaxoSmithKline PLC
26 November 2002



Issued - Tuesday 26 November 2002, London


                     GlaxoSmithKline Executive Remuneration


GlaxoSmithKline plc has held discussions with shareholders on the proposal to
increase the level of long-term incentive awards for Chief Executive Officer
(CEO), JP Garnier. The company remains committed to the policy of aligning its
incentive plans with those of its global pharmaceutical peer group. However,
after taking account of shareholder views the company has decided to postpone a
decision on this matter and will now take further time to consider the way
forward.


For 2002, the CEO's long-term incentive awards will be set at a similar level to
last year.

S M Bicknell

Company Secretary

26th November 2002



GSK Enquiries:
UK Media enquiries:                                     Martin Sutton            [phone]
                                                        Alan Chandler            [phone]
                                                        Siobhan Lavelle          [phone]

US Media enquiries:                                     Nancy Pekarek            [phone]
                                                        Mary Anne Rhyne          [phone]
                                                        Patricia Seif            [phone]

European Analyst/Investor enquiries:                    Duncan Learmouth         [phone]
                                                        Philip Thomson           [phone]

US Analyst/ Investor enquiries:                         Frank Murdolo            [phone]
                                                        Tom Curry                [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange